CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11
Authors
L.K. Tanno Chalmers, R. Bierrenbach, A.L. Simons, F.E.R. Martin, B. Molinari, N. Annesi-Maesano, I. Worm, M. Cardona, V. Papadopoulos, N.G. Sanchez-Borges, M. Rosenwasser, L.J. Ansontegui, I. Ebisawa, M. Sisul, J.C. Jares, E. Gomez, M. Agache, I. Hellings, P. Muraro, A. Thien, F. Pawankar, R. Sublett, J.L. Casale, T. Demoly, P. Joint Allergy Academies
Publication date
1 January 2019
Publisher
Abstract
We review the history of the classification and coding changes for anaphylaxis and provide current and perspective information in the field. In 2012, an analysis of Brazilian data demonstrated undernotification of anaphylaxis-related deaths because of the difficulties of coding using the International Classification of Diseases, 10th Revision. This work triggered strategic international actions supported by the Joint Allergy Academies and the International Classification of Diseases World Health Organization (WHO) leadership to update the classification of allergic disorders for the International Classification of Diseases, 11th Revision (ICD-11), which resulted in construction of the pioneer “Allergic and hypersensitivity conditions” chapter. The usability of the new framework has been tested by evaluating the same data published in 2012 from the ICD-11 perspective. Coding accuracy was much improved, reaching 95% for definite anaphylaxis. As the results were provided to the WHO Mortality Reference Group, coding rules have been changed, allowing anaphylaxis to be recorded as an underlying cause of death in official mortality statistics. The mandatory use of ICD-11 from January 2022 for documenting cause of death could have 2 immediate consequences: (1) the reported number of anaphylaxis-related deaths might increase because of more appropriate coding and (2) the cross-sectional and longitudinal mortality data generated might ultimately lead to a better understanding of anaphylaxis epidemiology and improved health policies directed at reducing anaphylaxis-related mortality. © 2019 American Academy of Allergy, Asthma & Immunolog
Similar works
Full text
Available Versions
Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:lib.uoa.gr:uoadl:3000385
Last time updated on 10/02/2023